nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—Fluoxymesterone—breast cancer	0.463	1	CrCtD
Amcinonide—NR3C1—Fluoxymesterone—breast cancer	0.131	1	CbGbCtD
Amcinonide—Prednisone—Exemestane—breast cancer	0.0254	0.0861	CrCrCtD
Amcinonide—Fluprednidene Acetate—Exemestane—breast cancer	0.0236	0.0799	CrCrCtD
Amcinonide—Loteprednol—Exemestane—breast cancer	0.0236	0.0799	CrCrCtD
Amcinonide—Prednisolone—Exemestane—breast cancer	0.0216	0.0731	CrCrCtD
Amcinonide—Cortisone acetate—Fluoxymesterone—breast cancer	0.0203	0.0687	CrCrCtD
Amcinonide—Fludrocortisone—Fluoxymesterone—breast cancer	0.0176	0.0597	CrCrCtD
Amcinonide—Clobetasol propionate—Fluoxymesterone—breast cancer	0.0176	0.0597	CrCrCtD
Amcinonide—Desoximetasone—Fluoxymesterone—breast cancer	0.0168	0.0567	CrCrCtD
Amcinonide—Fluorometholone—Fluoxymesterone—breast cancer	0.0164	0.0554	CrCrCtD
Amcinonide—Fluprednidene Acetate—Fluoxymesterone—breast cancer	0.0164	0.0554	CrCrCtD
Amcinonide—Loteprednol—Fluoxymesterone—breast cancer	0.0164	0.0554	CrCrCtD
Amcinonide—Mometasone—Fluoxymesterone—breast cancer	0.0164	0.0554	CrCrCtD
Amcinonide—Triamcinolone—Fluoxymesterone—breast cancer	0.0164	0.0554	CrCrCtD
Amcinonide—Dexamethasone—Fluoxymesterone—breast cancer	0.016	0.0541	CrCrCtD
Amcinonide—Betamethasone—Fluoxymesterone—breast cancer	0.016	0.0541	CrCrCtD
Amcinonide—Prednisolone—Fluoxymesterone—breast cancer	0.015	0.0507	CrCrCtD
Amcinonide—Dermatitis acneiform—Lapatinib—breast cancer	0.00238	0.0941	CcSEcCtD
Amcinonide—ANXA1—mammary gland—breast cancer	0.00238	0.101	CbGeAlD
Amcinonide—ANXA1—nipple—breast cancer	0.00196	0.0832	CbGeAlD
Amcinonide—Hypertrichosis—Exemestane—breast cancer	0.00171	0.0675	CcSEcCtD
Amcinonide—ANXA1—embryo—breast cancer	0.00162	0.0687	CbGeAlD
Amcinonide—ANXA1—epithelium—breast cancer	0.00132	0.056	CbGeAlD
Amcinonide—ANXA1—skin of body—breast cancer	0.00126	0.0533	CbGeAlD
Amcinonide—ANXA1—endometrium—breast cancer	0.00119	0.0503	CbGeAlD
Amcinonide—Telangiectasia—Fluorouracil—breast cancer	0.00113	0.0448	CcSEcCtD
Amcinonide—ANXA1—uterus—breast cancer	0.00109	0.0463	CbGeAlD
Amcinonide—ANXA1—pituitary gland—breast cancer	0.00107	0.0455	CbGeAlD
Amcinonide—ANXA1—adipose tissue—breast cancer	0.00107	0.0453	CbGeAlD
Amcinonide—ANXA1—female reproductive system—breast cancer	0.000983	0.0416	CbGeAlD
Amcinonide—ANXA1—adrenal gland—breast cancer	0.000959	0.0406	CbGeAlD
Amcinonide—ANXA1—bone marrow—breast cancer	0.000928	0.0393	CbGeAlD
Amcinonide—ANXA1—female gonad—breast cancer	0.000894	0.0379	CbGeAlD
Amcinonide—ANXA1—endocrine gland—breast cancer	0.000832	0.0352	CbGeAlD
Amcinonide—Allergic contact dermatitis—Fluorouracil—breast cancer	0.000763	0.0302	CcSEcCtD
Amcinonide—Leukoderma—Thiotepa—breast cancer	0.000758	0.03	CcSEcCtD
Amcinonide—NR3C1—nipple—breast cancer	0.000682	0.0289	CbGeAlD
Amcinonide—Tenderness—Raloxifene—breast cancer	0.000627	0.0248	CcSEcCtD
Amcinonide—Telangiectasia—Methotrexate—breast cancer	0.000589	0.0233	CcSEcCtD
Amcinonide—ANXA1—lymph node—breast cancer	0.000575	0.0244	CbGeAlD
Amcinonide—NR3C1—embryo—breast cancer	0.000563	0.0239	CbGeAlD
Amcinonide—Fluoxymesterone—PRLR—breast cancer	0.000525	0.224	CrCbGaD
Amcinonide—NR3C1—epithelium—breast cancer	0.000459	0.0195	CbGeAlD
Amcinonide—Tenderness—Tamoxifen—breast cancer	0.000452	0.0179	CcSEcCtD
Amcinonide—Secondary infection—Epirubicin—breast cancer	0.000442	0.0175	CcSEcCtD
Amcinonide—NR3C1—skin of body—breast cancer	0.000437	0.0185	CbGeAlD
Amcinonide—Tenderness—Goserelin—breast cancer	0.000432	0.0171	CcSEcCtD
Amcinonide—NR3C1—endometrium—breast cancer	0.000412	0.0175	CbGeAlD
Amcinonide—Secondary infection—Doxorubicin—breast cancer	0.000409	0.0162	CcSEcCtD
Amcinonide—NR3C1—uterus—breast cancer	0.00038	0.0161	CbGeAlD
Amcinonide—NR3C1—pituitary gland—breast cancer	0.000373	0.0158	CbGeAlD
Amcinonide—NR3C1—adipose tissue—breast cancer	0.000371	0.0157	CbGeAlD
Amcinonide—Folliculitis—Paclitaxel—breast cancer	0.000361	0.0143	CcSEcCtD
Amcinonide—NR3C1—female reproductive system—breast cancer	0.000341	0.0145	CbGeAlD
Amcinonide—NR3C1—adrenal gland—breast cancer	0.000333	0.0141	CbGeAlD
Amcinonide—Stinging—Fluorouracil—breast cancer	0.000329	0.013	CcSEcCtD
Amcinonide—Leukoderma—Methotrexate—breast cancer	0.000326	0.0129	CcSEcCtD
Amcinonide—NR3C1—bone marrow—breast cancer	0.000322	0.0137	CbGeAlD
Amcinonide—Dermatitis contact—Thiotepa—breast cancer	0.000319	0.0126	CcSEcCtD
Amcinonide—Tenderness—Gemcitabine—breast cancer	0.000311	0.0123	CcSEcCtD
Amcinonide—NR3C1—female gonad—breast cancer	0.000311	0.0132	CbGeAlD
Amcinonide—Tenderness—Fluorouracil—breast cancer	0.000306	0.0121	CcSEcCtD
Amcinonide—Infection—Carboplatin—breast cancer	0.000305	0.0121	CcSEcCtD
Amcinonide—Leukoderma—Epirubicin—breast cancer	0.000305	0.0121	CcSEcCtD
Amcinonide—NR3C1—endocrine gland—breast cancer	0.000289	0.0122	CbGeAlD
Amcinonide—Infection—Lapatinib—breast cancer	0.000288	0.0114	CcSEcCtD
Amcinonide—Leukoderma—Doxorubicin—breast cancer	0.000283	0.0112	CcSEcCtD
Amcinonide—Infection—Fulvestrant—breast cancer	0.000265	0.0105	CcSEcCtD
Amcinonide—Dermatitis contact—Fluorouracil—breast cancer	0.000263	0.0104	CcSEcCtD
Amcinonide—Pain—Carboplatin—breast cancer	0.000263	0.0104	CcSEcCtD
Amcinonide—Tenderness—Paclitaxel—breast cancer	0.00026	0.0103	CcSEcCtD
Amcinonide—Infection—Exemestane—breast cancer	0.00023	0.0091	CcSEcCtD
Amcinonide—Pain—Fulvestrant—breast cancer	0.000228	0.00902	CcSEcCtD
Amcinonide—Pain—Toremifene—breast cancer	0.000225	0.0089	CcSEcCtD
Amcinonide—Folliculitis—Methotrexate—breast cancer	0.000221	0.00873	CcSEcCtD
Amcinonide—Infection—Ixabepilone—breast cancer	0.000217	0.00858	CcSEcCtD
Amcinonide—Folliculitis—Epirubicin—breast cancer	0.000207	0.00817	CcSEcCtD
Amcinonide—Pruritus—Lapatinib—breast cancer	0.000205	0.00811	CcSEcCtD
Amcinonide—Infection—Anastrozole—breast cancer	0.000204	0.00808	CcSEcCtD
Amcinonide—Infection—Letrozole—breast cancer	0.000204	0.00808	CcSEcCtD
Amcinonide—NR3C1—lymph node—breast cancer	0.0002	0.00846	CbGeAlD
Amcinonide—Pain—Exemestane—breast cancer	0.000198	0.00783	CcSEcCtD
Amcinonide—Infection—Raloxifene—breast cancer	0.000194	0.00767	CcSEcCtD
Amcinonide—Infection—Idarubicin—breast cancer	0.000194	0.00767	CcSEcCtD
Amcinonide—Folliculitis—Doxorubicin—breast cancer	0.000191	0.00756	CcSEcCtD
Amcinonide—Pruritus—Fulvestrant—breast cancer	0.000189	0.00746	CcSEcCtD
Amcinonide—Pain—Ixabepilone—breast cancer	0.000187	0.00739	CcSEcCtD
Amcinonide—Pruritus—Toremifene—breast cancer	0.000186	0.00736	CcSEcCtD
Amcinonide—Dermatitis—Lapatinib—breast cancer	0.000183	0.00722	CcSEcCtD
Amcinonide—Pain—Letrozole—breast cancer	0.000176	0.00696	CcSEcCtD
Amcinonide—Pain—Anastrozole—breast cancer	0.000176	0.00696	CcSEcCtD
Amcinonide—Fluocinolone Acetonide—PLA2G4A—breast cancer	0.000175	0.0746	CrCbGaD
Amcinonide—Dermatitis—Fulvestrant—breast cancer	0.000168	0.00664	CcSEcCtD
Amcinonide—Pain—Raloxifene—breast cancer	0.000167	0.0066	CcSEcCtD
Amcinonide—Dermatitis—Toremifene—breast cancer	0.000166	0.00655	CcSEcCtD
Amcinonide—Pruritus—Exemestane—breast cancer	0.000164	0.00648	CcSEcCtD
Amcinonide—Rash pustular—Epirubicin—breast cancer	0.000163	0.00644	CcSEcCtD
Amcinonide—Stinging—Epirubicin—breast cancer	0.00016	0.00634	CcSEcCtD
Amcinonide—Infection—Chlorambucil—breast cancer	0.000157	0.00621	CcSEcCtD
Amcinonide—Pruritus—Ixabepilone—breast cancer	0.000155	0.00611	CcSEcCtD
Amcinonide—Rash pustular—Doxorubicin—breast cancer	0.000151	0.00596	CcSEcCtD
Amcinonide—Stinging—Doxorubicin—breast cancer	0.000148	0.00586	CcSEcCtD
Amcinonide—Dermatitis—Exemestane—breast cancer	0.000146	0.00577	CcSEcCtD
Amcinonide—Pruritus—Anastrozole—breast cancer	0.000146	0.00576	CcSEcCtD
Amcinonide—Pruritus—Letrozole—breast cancer	0.000146	0.00576	CcSEcCtD
Amcinonide—Infection—Tamoxifen—breast cancer	0.00014	0.00553	CcSEcCtD
Amcinonide—Dermatitis—Ixabepilone—breast cancer	0.000138	0.00544	CcSEcCtD
Amcinonide—Infection—Melphalan—breast cancer	0.000137	0.00542	CcSEcCtD
Amcinonide—Pain—Chlorambucil—breast cancer	0.000135	0.00535	CcSEcCtD
Amcinonide—Infection—Goserelin—breast cancer	0.000134	0.00528	CcSEcCtD
Amcinonide—Dermatitis—Letrozole—breast cancer	0.00013	0.00513	CcSEcCtD
Amcinonide—Dermatitis—Anastrozole—breast cancer	0.00013	0.00513	CcSEcCtD
Amcinonide—Dermatitis contact—Epirubicin—breast cancer	0.000128	0.00507	CcSEcCtD
Amcinonide—Pain—Vinblastine—breast cancer	0.000124	0.0049	CcSEcCtD
Amcinonide—Dermatitis—Raloxifene—breast cancer	0.000123	0.00486	CcSEcCtD
Amcinonide—Dermatitis—Idarubicin—breast cancer	0.000123	0.00486	CcSEcCtD
Amcinonide—Pain—Tamoxifen—breast cancer	0.00012	0.00476	CcSEcCtD
Amcinonide—Infection—Vinorelbine—breast cancer	0.00012	0.00473	CcSEcCtD
Amcinonide—Fluticasone Propionate—PLA2G4A—breast cancer	0.000119	0.051	CrCbGaD
Amcinonide—Dermatitis contact—Doxorubicin—breast cancer	0.000119	0.00469	CcSEcCtD
Amcinonide—Pain—Melphalan—breast cancer	0.000118	0.00466	CcSEcCtD
Amcinonide—Pain—Goserelin—breast cancer	0.000115	0.00455	CcSEcCtD
Amcinonide—Infection—Thiotepa—breast cancer	0.000114	0.00452	CcSEcCtD
Amcinonide—Pruritus—Chlorambucil—breast cancer	0.000112	0.00443	CcSEcCtD
Amcinonide—Pain—Vinorelbine—breast cancer	0.000103	0.00407	CcSEcCtD
Amcinonide—Pruritus—Tamoxifen—breast cancer	9.96e-05	0.00394	CcSEcCtD
Amcinonide—Infection—Irinotecan—breast cancer	9.87e-05	0.0039	CcSEcCtD
Amcinonide—Infection—Mitoxantrone—breast cancer	9.87e-05	0.0039	CcSEcCtD
Amcinonide—Pain—Thiotepa—breast cancer	9.84e-05	0.00389	CcSEcCtD
Amcinonide—Pruritus—Melphalan—breast cancer	9.75e-05	0.00386	CcSEcCtD
Amcinonide—Infection—Gemcitabine—breast cancer	9.61e-05	0.0038	CcSEcCtD
Amcinonide—Pruritus—Goserelin—breast cancer	9.51e-05	0.00376	CcSEcCtD
Amcinonide—Infection—Fluorouracil—breast cancer	9.45e-05	0.00374	CcSEcCtD
Amcinonide—Fludrocortisone—AR—breast cancer	9.22e-05	0.0394	CrCbGaD
Amcinonide—Dermatitis—Tamoxifen—breast cancer	8.87e-05	0.00351	CcSEcCtD
Amcinonide—Dermatitis—Melphalan—breast cancer	8.68e-05	0.00343	CcSEcCtD
Amcinonide—Fluoxymesterone—SHBG—breast cancer	8.68e-05	0.0371	CrCbGaD
Amcinonide—Pruritus—Vinorelbine—breast cancer	8.52e-05	0.00337	CcSEcCtD
Amcinonide—Pain—Mitoxantrone—breast cancer	8.49e-05	0.00336	CcSEcCtD
Amcinonide—Pain—Irinotecan—breast cancer	8.49e-05	0.00336	CcSEcCtD
Amcinonide—Dermatitis—Goserelin—breast cancer	8.47e-05	0.00335	CcSEcCtD
Amcinonide—Pain—Gemcitabine—breast cancer	8.27e-05	0.00327	CcSEcCtD
Amcinonide—Pruritus—Thiotepa—breast cancer	8.14e-05	0.00322	CcSEcCtD
Amcinonide—Pain—Fluorouracil—breast cancer	8.13e-05	0.00322	CcSEcCtD
Amcinonide—Infection—Paclitaxel—breast cancer	8.05e-05	0.00318	CcSEcCtD
Amcinonide—Fluticasone Propionate—PGR—breast cancer	7.9e-05	0.0337	CrCbGaD
Amcinonide—Fluoxymesterone—AR—breast cancer	7.61e-05	0.0325	CrCbGaD
Amcinonide—Dermatitis—Vinorelbine—breast cancer	7.59e-05	0.003	CcSEcCtD
Amcinonide—Dermatitis—Thiotepa—breast cancer	7.24e-05	0.00287	CcSEcCtD
Amcinonide—Betamethasone—PGR—breast cancer	7.24e-05	0.0309	CrCbGaD
Amcinonide—Pain—Paclitaxel—breast cancer	6.93e-05	0.00274	CcSEcCtD
Amcinonide—Pruritus—Gemcitabine—breast cancer	6.84e-05	0.00271	CcSEcCtD
Amcinonide—Infection—Docetaxel—breast cancer	6.82e-05	0.0027	CcSEcCtD
Amcinonide—Pruritus—Fluorouracil—breast cancer	6.73e-05	0.00266	CcSEcCtD
Amcinonide—Infection—Capecitabine—breast cancer	6.6e-05	0.00261	CcSEcCtD
Amcinonide—Dermatitis—Mitoxantrone—breast cancer	6.26e-05	0.00247	CcSEcCtD
Amcinonide—Dermatitis—Irinotecan—breast cancer	6.26e-05	0.00247	CcSEcCtD
Amcinonide—Dermatitis—Gemcitabine—breast cancer	6.09e-05	0.00241	CcSEcCtD
Amcinonide—Triamcinolone—BCHE—breast cancer	6.05e-05	0.0258	CrCbGaD
Amcinonide—Dermatitis—Fluorouracil—breast cancer	5.99e-05	0.00237	CcSEcCtD
Amcinonide—Pain—Docetaxel—breast cancer	5.87e-05	0.00232	CcSEcCtD
Amcinonide—Fluoxymesterone—ESR1—breast cancer	5.86e-05	0.025	CrCbGaD
Amcinonide—Pruritus—Paclitaxel—breast cancer	5.73e-05	0.00227	CcSEcCtD
Amcinonide—Pain—Capecitabine—breast cancer	5.68e-05	0.00225	CcSEcCtD
Amcinonide—Clobetasol propionate—CYP1A1—breast cancer	5.68e-05	0.0242	CrCbGaD
Amcinonide—Dexamethasone—CYP17A1—breast cancer	5.68e-05	0.0242	CrCbGaD
Amcinonide—Dermatitis—Paclitaxel—breast cancer	5.1e-05	0.00202	CcSEcCtD
Amcinonide—Betamethasone—CYP19A1—breast cancer	4.96e-05	0.0212	CrCbGaD
Amcinonide—Infection—Methotrexate—breast cancer	4.92e-05	0.00194	CcSEcCtD
Amcinonide—Pruritus—Docetaxel—breast cancer	4.86e-05	0.00192	CcSEcCtD
Amcinonide—Pruritus—Capecitabine—breast cancer	4.7e-05	0.00186	CcSEcCtD
Amcinonide—Dexamethasone—NOS2—breast cancer	4.63e-05	0.0198	CrCbGaD
Amcinonide—Infection—Epirubicin—breast cancer	4.6e-05	0.00182	CcSEcCtD
Amcinonide—Cortisone acetate—CYP3A4—breast cancer	4.57e-05	0.0195	CrCbGaD
Amcinonide—Dermatitis—Docetaxel—breast cancer	4.33e-05	0.00171	CcSEcCtD
Amcinonide—Budesonide—CYP3A4—breast cancer	4.32e-05	0.0184	CrCbGaD
Amcinonide—Infection—Doxorubicin—breast cancer	4.26e-05	0.00168	CcSEcCtD
Amcinonide—Fluticasone furoate—CYP3A4—breast cancer	4.23e-05	0.0181	CrCbGaD
Amcinonide—Pain—Methotrexate—breast cancer	4.23e-05	0.00167	CcSEcCtD
Amcinonide—Dexamethasone—PGR—breast cancer	4.21e-05	0.018	CrCbGaD
Amcinonide—Dermatitis—Capecitabine—breast cancer	4.19e-05	0.00166	CcSEcCtD
Amcinonide—Ciclesonide—CYP2D6—breast cancer	4.1e-05	0.0175	CrCbGaD
Amcinonide—Pain—Epirubicin—breast cancer	3.96e-05	0.00157	CcSEcCtD
Amcinonide—Dexamethasone—CYP1B1—breast cancer	3.93e-05	0.0168	CrCbGaD
Amcinonide—Pain—Doxorubicin—breast cancer	3.66e-05	0.00145	CcSEcCtD
Amcinonide—Flunisolide—CYP3A4—breast cancer	3.62e-05	0.0155	CrCbGaD
Amcinonide—Fluticasone furoate—ABCB1—breast cancer	3.53e-05	0.0151	CrCbGaD
Amcinonide—Ciclesonide—CYP3A4—breast cancer	3.52e-05	0.015	CrCbGaD
Amcinonide—Pruritus—Methotrexate—breast cancer	3.5e-05	0.00138	CcSEcCtD
Amcinonide—Fluorometholone—CYP3A4—breast cancer	3.49e-05	0.0149	CrCbGaD
Amcinonide—Pruritus—Epirubicin—breast cancer	3.28e-05	0.0013	CcSEcCtD
Amcinonide—Dermatitis—Methotrexate—breast cancer	3.12e-05	0.00123	CcSEcCtD
Amcinonide—Pruritus—Doxorubicin—breast cancer	3.03e-05	0.0012	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—RGS2—breast cancer	2.97e-05	0.000499	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—breast cancer	2.94e-05	0.000495	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—breast cancer	2.94e-05	0.000494	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCL20—breast cancer	2.93e-05	0.000493	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AGTR1—breast cancer	2.93e-05	0.000492	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NR2F6—breast cancer	2.92e-05	0.000491	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HNF4G—breast cancer	2.92e-05	0.000491	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—breast cancer	2.92e-05	0.00049	CbGpPWpGaD
Amcinonide—Dermatitis—Epirubicin—breast cancer	2.92e-05	0.00115	CcSEcCtD
Amcinonide—ANXA1—GPCR downstream signaling—ITPR1—breast cancer	2.89e-05	0.000486	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP19A1—breast cancer	2.89e-05	0.0123	CrCbGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—breast cancer	2.88e-05	0.000484	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—breast cancer	2.85e-05	0.00048	CbGpPWpGaD
Amcinonide—Triamcinolone—CYP3A4—breast cancer	2.85e-05	0.0122	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—TLE3—breast cancer	2.84e-05	0.000477	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LPAR1—breast cancer	2.84e-05	0.000477	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HEY1—breast cancer	2.81e-05	0.000473	CbGpPWpGaD
Amcinonide—Triamcinolone—PTGS2—breast cancer	2.79e-05	0.0119	CrCbGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—breast cancer	2.79e-05	0.000468	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DLL1—breast cancer	2.76e-05	0.000463	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—RB1—breast cancer	2.75e-05	0.000462	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—TGFB1—breast cancer	2.74e-05	0.000461	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IGF1—breast cancer	2.72e-05	0.000458	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—breast cancer	2.72e-05	0.000457	CbGpPWpGaD
Amcinonide—Dexamethasone—ABCG2—breast cancer	2.71e-05	0.0116	CrCbGaD
Amcinonide—NR3C1—Generic Transcription Pathway—RARB—breast cancer	2.71e-05	0.000455	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HIST1H2BK—breast cancer	2.71e-05	0.000455	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HIST1H2BC—breast cancer	2.71e-05	0.000455	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	2.7e-05	0.000454	CbGpPWpGaD
Amcinonide—Dermatitis—Doxorubicin—breast cancer	2.7e-05	0.00107	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—MYC—breast cancer	2.69e-05	0.000451	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GRB7—breast cancer	2.68e-05	0.000451	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PDE4D—breast cancer	2.68e-05	0.000451	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TGFB1—breast cancer	2.68e-05	0.00045	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CSF2—breast cancer	2.67e-05	0.000449	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	2.64e-05	0.000444	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TAB2—breast cancer	2.64e-05	0.000443	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—ITPR1—breast cancer	2.63e-05	0.000441	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CNR2—breast cancer	2.61e-05	0.000439	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCL8—breast cancer	2.61e-05	0.000439	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MMP3—breast cancer	2.61e-05	0.000438	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	2.6e-05	0.000437	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HNRNPL—breast cancer	2.6e-05	0.000437	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—MED12—breast cancer	2.6e-05	0.000436	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—SERPINE1—breast cancer	2.59e-05	0.000435	CbGpPWpGaD
Amcinonide—Prednisone—CYP3A4—breast cancer	2.58e-05	0.011	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—DKK1—breast cancer	2.55e-05	0.000429	CbGpPWpGaD
Amcinonide—Fluticasone Propionate—CYP3A4—breast cancer	2.54e-05	0.0109	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFC—breast cancer	2.53e-05	0.000426	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JAG2—breast cancer	2.49e-05	0.000419	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—WNT1—breast cancer	2.46e-05	0.000413	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PLA2G4A—breast cancer	2.45e-05	0.000412	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—breast cancer	2.43e-05	0.000409	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CSF2—breast cancer	2.43e-05	0.000408	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—breast cancer	2.39e-05	0.000402	CbGpPWpGaD
Amcinonide—Prednisolone—CYP3A4—breast cancer	2.38e-05	0.0102	CrCbGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NOTCH4—breast cancer	2.35e-05	0.000395	CbGpPWpGaD
Amcinonide—Betamethasone—CYP3A4—breast cancer	2.33e-05	0.00996	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—NOTCH4—breast cancer	2.33e-05	0.000392	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GZMB—breast cancer	2.32e-05	0.000389	CbGpPWpGaD
Amcinonide—Betamethasone—PTGS2—breast cancer	2.28e-05	0.00975	CrCbGaD
Amcinonide—Prednisone—ALB—breast cancer	2.25e-05	0.00962	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—AGTR2—breast cancer	2.25e-05	0.000378	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL2—breast cancer	2.25e-05	0.000378	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTHLH—breast cancer	2.22e-05	0.000374	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—BMP2—breast cancer	2.22e-05	0.000374	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—breast cancer	2.21e-05	0.000371	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EDNRB—breast cancer	2.15e-05	0.000362	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PGR—breast cancer	2.15e-05	0.000362	CbGpPWpGaD
Amcinonide—Prednisone—ABCB1—breast cancer	2.15e-05	0.00918	CrCbGaD
Amcinonide—NR3C1—Gene Expression—EIF2S2—breast cancer	2.14e-05	0.00036	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PGR—breast cancer	2.13e-05	0.000358	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP1A1—breast cancer	2.12e-05	0.00907	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—THBS1—breast cancer	2.12e-05	0.000356	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ESRRA—breast cancer	2.08e-05	0.00035	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NCOA2—breast cancer	2.07e-05	0.000348	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FLT1—breast cancer	2.02e-05	0.00034	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—CTNNB1—breast cancer	2.02e-05	0.00034	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL6—breast cancer	2.02e-05	0.000339	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGF3—breast cancer	2.02e-05	0.000339	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SQSTM1—breast cancer	2.02e-05	0.000339	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CG—breast cancer	2.01e-05	0.000337	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NOTCH3—breast cancer	2e-05	0.000336	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PARP1—breast cancer	2e-05	0.000336	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JAG1—breast cancer	1.99e-05	0.000334	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOTCH3—breast cancer	1.98e-05	0.000333	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PARP1—breast cancer	1.98e-05	0.000333	CbGpPWpGaD
Amcinonide—Prednisolone—ABCB1—breast cancer	1.98e-05	0.00846	CrCbGaD
Amcinonide—NR3C1—Adipogenesis—CDKN1A—breast cancer	1.97e-05	0.000332	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—YBX1—breast cancer	1.97e-05	0.000331	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CALCA—breast cancer	1.96e-05	0.000329	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—breast cancer	1.94e-05	0.000327	CbGpPWpGaD
Amcinonide—Betamethasone—ABCB1—breast cancer	1.94e-05	0.00829	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—RPS6—breast cancer	1.93e-05	0.000325	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGF4—breast cancer	1.92e-05	0.000322	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCR4—breast cancer	1.91e-05	0.000321	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL12—breast cancer	1.91e-05	0.000321	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—ESR2—breast cancer	1.89e-05	0.000318	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—breast cancer	1.89e-05	0.000318	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EEF2—breast cancer	1.88e-05	0.000316	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—THRB—breast cancer	1.88e-05	0.000316	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PAK1—breast cancer	1.88e-05	0.000315	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TCF7L2—breast cancer	1.84e-05	0.00031	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT2—breast cancer	1.84e-05	0.000308	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CG—breast cancer	1.82e-05	0.000306	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—breast cancer	1.82e-05	0.000305	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—breast cancer	1.81e-05	0.000304	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RXRB—breast cancer	1.8e-05	0.000303	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—TET2—breast cancer	1.8e-05	0.000303	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NOTCH2—breast cancer	1.79e-05	0.000302	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—breast cancer	1.78e-05	0.000299	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOTCH2—breast cancer	1.78e-05	0.000299	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HSP90AA1—breast cancer	1.78e-05	0.000299	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPL31—breast cancer	1.77e-05	0.000297	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CD—breast cancer	1.76e-05	0.000296	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—STAT3—breast cancer	1.76e-05	0.000296	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—JUN—breast cancer	1.76e-05	0.000296	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—breast cancer	1.75e-05	0.000293	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NCOA1—breast cancer	1.75e-05	0.000293	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AGTR1—breast cancer	1.73e-05	0.000291	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRL—breast cancer	1.73e-05	0.000291	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADAM10—breast cancer	1.7e-05	0.000286	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—STK11—breast cancer	1.7e-05	0.000286	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PLG—breast cancer	1.69e-05	0.000283	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—AR—breast cancer	1.67e-05	0.000281	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT2—breast cancer	1.67e-05	0.00028	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGF10—breast cancer	1.66e-05	0.000279	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—breast cancer	1.66e-05	0.000278	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPS4X—breast cancer	1.65e-05	0.000277	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—breast cancer	1.64e-05	0.000276	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TGFB1—breast cancer	1.63e-05	0.000274	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EIF3A—breast cancer	1.62e-05	0.000273	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CD—breast cancer	1.6e-05	0.000269	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—DNMT3A—breast cancer	1.6e-05	0.000269	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PDGFA—breast cancer	1.6e-05	0.000269	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP2D6—breast cancer	1.58e-05	0.00675	CrCbGaD
Amcinonide—NR3C1—Gene Expression—ELL—breast cancer	1.58e-05	0.000265	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TGFBR2—breast cancer	1.58e-05	0.000265	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ITPR1—breast cancer	1.55e-05	0.000261	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—STAT5A—breast cancer	1.54e-05	0.000259	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP3—breast cancer	1.54e-05	0.000259	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ERBB4—breast cancer	1.54e-05	0.000259	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—breast cancer	1.54e-05	0.000258	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CB—breast cancer	1.54e-05	0.000258	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—breast cancer	1.52e-05	0.000256	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—SMAD4—breast cancer	1.51e-05	0.000253	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—VDR—breast cancer	1.5e-05	0.000253	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SMAD4—breast cancer	1.49e-05	0.000251	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1R—breast cancer	1.48e-05	0.000249	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL8—breast cancer	1.48e-05	0.000248	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NCOR1—breast cancer	1.46e-05	0.000246	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PABPC1—breast cancer	1.46e-05	0.000245	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HES1—breast cancer	1.46e-05	0.000245	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PLA2G4A—breast cancer	1.45e-05	0.000243	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NCOR1—breast cancer	1.45e-05	0.000243	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGF1—breast cancer	1.43e-05	0.000241	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CSF2—breast cancer	1.43e-05	0.000241	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—RAF1—breast cancer	1.43e-05	0.00024	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NRG1—breast cancer	1.42e-05	0.000239	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—H2AFX—breast cancer	1.41e-05	0.000237	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—IL2—breast cancer	1.41e-05	0.000237	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—E2F1—breast cancer	1.4e-05	0.000236	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CB—breast cancer	1.4e-05	0.000234	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—DNMT3B—breast cancer	1.37e-05	0.00023	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP3A4—breast cancer	1.36e-05	0.00579	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—SPP1—breast cancer	1.35e-05	0.000226	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL8—breast cancer	1.34e-05	0.000225	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPL23A—breast cancer	1.34e-05	0.000225	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ERBB3—breast cancer	1.33e-05	0.000224	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGFR2—breast cancer	1.33e-05	0.000224	CbGpPWpGaD
Amcinonide—Dexamethasone—PTGS2—breast cancer	1.33e-05	0.00567	CrCbGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—breast cancer	1.32e-05	0.000221	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HIST1H2BC—breast cancer	1.32e-05	0.000221	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HIST1H2BK—breast cancer	1.32e-05	0.000221	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RARB—breast cancer	1.3e-05	0.000219	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL2—breast cancer	1.28e-05	0.000215	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TERT—breast cancer	1.28e-05	0.000215	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPS7—breast cancer	1.25e-05	0.00021	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPS8—breast cancer	1.25e-05	0.00021	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MED12—breast cancer	1.25e-05	0.00021	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGFR1—breast cancer	1.24e-05	0.000208	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IL6—breast cancer	1.23e-05	0.000207	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HIF1A—breast cancer	1.22e-05	0.000205	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LEP—breast cancer	1.19e-05	0.0002	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CAV1—breast cancer	1.18e-05	0.000198	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KDR—breast cancer	1.17e-05	0.000196	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—ESR1—breast cancer	1.15e-05	0.000193	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ESR1—breast cancer	1.14e-05	0.000191	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NOTCH4—breast cancer	1.13e-05	0.00019	CbGpPWpGaD
Amcinonide—Dexamethasone—ABCB1—breast cancer	1.13e-05	0.00482	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—FN1—breast cancer	1.12e-05	0.000189	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NFKBIA—breast cancer	1.11e-05	0.000187	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NOTCH1—breast cancer	1.11e-05	0.000187	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOTCH1—breast cancer	1.1e-05	0.000185	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HSPA1B—breast cancer	1.08e-05	0.000182	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APC—breast cancer	1.08e-05	0.000181	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CG—breast cancer	1.08e-05	0.000181	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KIT—breast cancer	1.08e-05	0.000181	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGF—breast cancer	1.06e-05	0.000179	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6—breast cancer	1.06e-05	0.000179	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PGR—breast cancer	1.04e-05	0.000174	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MAPK3—breast cancer	1.03e-05	0.000173	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—DNMT1—breast cancer	1.02e-05	0.000171	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—BRAF—breast cancer	1.01e-05	0.00017	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NCOA2—breast cancer	9.97e-06	0.000168	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1—breast cancer	9.85e-06	0.000166	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT2—breast cancer	9.84e-06	0.000165	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EZH2—breast cancer	9.84e-06	0.000165	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EGFR—breast cancer	9.8e-06	0.000165	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NOTCH3—breast cancer	9.63e-06	0.000162	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PARP1—breast cancer	9.63e-06	0.000162	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CD—breast cancer	9.46e-06	0.000159	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—SERPINE1—breast cancer	9.44e-06	0.000159	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPS6—breast cancer	9.4e-06	0.000158	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CA—breast cancer	9.37e-06	0.000157	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SERPINE1—breast cancer	9.35e-06	0.000157	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—KRAS—breast cancer	9.26e-06	0.000156	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ESR2—breast cancer	9.12e-06	0.000153	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOS3—breast cancer	8.93e-06	0.00015	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NOTCH2—breast cancer	8.64e-06	0.000145	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CA—breast cancer	8.51e-06	0.000143	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MDM2—breast cancer	8.47e-06	0.000142	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RAF1—breast cancer	8.44e-06	0.000142	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RELA—breast cancer	8.41e-06	0.000141	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NCOA1—breast cancer	8.4e-06	0.000141	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ERBB2—breast cancer	8.35e-06	0.00014	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CB—breast cancer	8.24e-06	0.000139	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MTOR—breast cancer	8.24e-06	0.000139	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AR—breast cancer	8.06e-06	0.000135	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL8—breast cancer	7.92e-06	0.000133	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HRAS—breast cancer	7.87e-06	0.000132	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CDKN1B—breast cancer	7.74e-06	0.00013	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT1—breast cancer	7.65e-06	0.000129	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CASP3—breast cancer	7.58e-06	0.000127	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL2—breast cancer	7.57e-06	0.000127	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6—breast cancer	7.53e-06	0.000127	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCND1—breast cancer	7.38e-06	0.000124	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JUN—breast cancer	7.37e-06	0.000124	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SIRT1—breast cancer	7.35e-06	0.000123	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CTNNB1—breast cancer	7.31e-06	0.000123	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SMAD4—breast cancer	7.25e-06	0.000122	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—VDR—breast cancer	7.24e-06	0.000122	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP9—breast cancer	7.17e-06	0.00012	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CDKN1A—breast cancer	7.14e-06	0.00012	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTEN—breast cancer	7.12e-06	0.00012	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NCOR1—breast cancer	7.04e-06	0.000118	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAPK8—breast cancer	6.97e-06	0.000117	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT1—breast cancer	6.95e-06	0.000117	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—H2AFX—breast cancer	6.86e-06	0.000115	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ERCC2—breast cancer	6.62e-06	0.000111	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SRC—breast cancer	6.61e-06	0.000111	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—breast cancer	6.43e-06	0.000108	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—STAT3—breast cancer	6.37e-06	0.000107	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAPK3—breast cancer	6.09e-06	0.000102	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—MYC—breast cancer	5.98e-06	0.0001	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MYC—breast cancer	5.92e-06	9.95e-05	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TGFB1—breast cancer	5.91e-06	9.92e-05	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGFR—breast cancer	5.79e-06	9.73e-05	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ESR1—breast cancer	5.53e-06	9.3e-05	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KRAS—breast cancer	5.47e-06	9.19e-05	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NOTCH1—breast cancer	5.35e-06	8.99e-05	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CA—breast cancer	5.03e-06	8.44e-05	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—breast cancer	4.86e-06	8.17e-05	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HRAS—breast cancer	4.65e-06	7.81e-05	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SERPINE1—breast cancer	4.55e-06	7.64e-05	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6—breast cancer	4.45e-06	7.48e-05	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT1—breast cancer	4.11e-06	6.9e-05	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MAPK3—breast cancer	2.96e-06	4.97e-05	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MYC—breast cancer	2.88e-06	4.84e-05	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AKT1—breast cancer	2e-06	3.35e-05	CbGpPWpGaD
